Systemic Therapy for Microsatellite Instability Small Bowel Adenocarcinoma With Mesenteric Vascular Embolism as

Zhongyi Dong1, Xiang Xia1, Zizhen Zhang1

  • 1Department of Gastrointestinal Surgery, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.

Frontiers in Medicine
|November 25, 2021
PubMed

Insights

Small bowel adenocarcinoma, a rare digestive tumor, can present with mesenteric vascular issues. A combination of surgery, chemotherapy, and anti-Programmed cell death protein 1 (PD-1) therapy led to complete remission in a Stage IV case.

Area of Science:

  • Gastroenterology
  • Oncology
  • Surgical Oncology

Background:

  • Small bowel adenocarcinoma is a rare malignancy often diagnosed at advanced stages due to limited screening.
  • Current treatment lacks specific surgical and chemotherapeutic guidelines.
  • Mesenteric vascular complications can be associated with small intestinal tumors.

Observation:

  • A 55-year-old male presented with symptoms suggestive of small bowel adenocarcinoma, including incomplete ileus, mesenteric vascular occlusion, and metastasis.
  • Palliative surgery was performed to resect the adenocarcinoma and alleviate the obstruction.
  • Pathological and immunohistochemical analysis revealed Stage IV adenocarcinoma with microsatellite instability.

Findings:

  • The patient received the XELOX chemotherapy regimen combined with anti-Programmed cell death protein 1 (PD-1) therapy.
  • Following treatment, the patient achieved complete remission.
  • A two-year follow-up confirmed the sustained remission.

Implications:

  • Mesenteric vascular obstruction should prompt consideration of small intestinal tumors.
  • Anti-PD-1 therapy demonstrates efficacy in treating microsatellite instability-high small bowel adenocarcinoma.
  • This case highlights a successful multimodal treatment approach for advanced small bowel adenocarcinoma.

Related Concept Videos